Check out the new and improved FierceVaccines website

Arsalan Arif, Publisher
Follow me on Twitter and LinkedIn

Dear readers: We've completed a major overhaul of FierceVaccines' website.

We had one guiding principle with the redesign. It's best captured by Jay Rosen, a prominent press critic and journalism professor at NYU:

"The simplest way to create value in journalism is to save the user time."

Please explore the streamlined new design and let us know if we indeed are saving you time. You, our readers, are some of the busiest executives in the world, so our mission is to give you great content and context in the daily vaccines news picture as expeditiously as possible. Drop me a line, tell us how we're doing in that regard. After all, we built it for you.

 

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.